CN103597098A - 病毒诊断 - Google Patents

病毒诊断 Download PDF

Info

Publication number
CN103597098A
CN103597098A CN201280012143.3A CN201280012143A CN103597098A CN 103597098 A CN103597098 A CN 103597098A CN 201280012143 A CN201280012143 A CN 201280012143A CN 103597098 A CN103597098 A CN 103597098A
Authority
CN
China
Prior art keywords
lcmv
seq
antibody
primer
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280012143.3A
Other languages
English (en)
Chinese (zh)
Inventor
J.托马斯科瓦
J.科帕塞克
J.帕斯托雷克
S.帕斯托雷科瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSCIENCE SLOVAKIA
Original Assignee
BIOSCIENCE SLOVAKIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSCIENCE SLOVAKIA filed Critical BIOSCIENCE SLOVAKIA
Publication of CN103597098A publication Critical patent/CN103597098A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201280012143.3A 2011-01-07 2012-01-06 病毒诊断 Pending CN103597098A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161430822P 2011-01-07 2011-01-07
US61/430,822 2011-01-07
PCT/IB2012/000293 WO2012093340A2 (en) 2011-01-07 2012-01-06 Viral diagnostics

Publications (1)

Publication Number Publication Date
CN103597098A true CN103597098A (zh) 2014-02-19

Family

ID=45878971

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280012143.3A Pending CN103597098A (zh) 2011-01-07 2012-01-06 病毒诊断

Country Status (7)

Country Link
US (1) US8883429B2 (cg-RX-API-DMAC7.html)
EP (2) EP2661509A2 (cg-RX-API-DMAC7.html)
JP (1) JP2014502848A (cg-RX-API-DMAC7.html)
CN (1) CN103597098A (cg-RX-API-DMAC7.html)
AU (1) AU2012204757A1 (cg-RX-API-DMAC7.html)
CA (1) CA2823876A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012093340A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996802A (zh) * 2018-09-12 2021-06-18 阿巴洛斯治疗有限公司 用于制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体
CN119080935A (zh) * 2024-10-11 2024-12-06 上海市同仁医院 一种抗人SMIM45-107aa单克隆抗体及其用途

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103993012B (zh) 2007-12-27 2023-01-10 苏黎士大学 复制缺陷型沙粒病毒载体
WO2011063127A1 (en) 2009-11-18 2011-05-26 University Of Medicine And Dentistry Of New Jersey Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
US9849192B2 (en) 2009-11-18 2017-12-26 Rutgers, The State University Of New Jersey Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
EP2904015A4 (en) 2012-10-02 2016-10-05 Univ Rutgers TARGETED RELEASE OF ANTIBODIES TO ACTIVATED MATRIPTASE-CONJUGATED TOXINS
US9809801B2 (en) 2013-03-15 2017-11-07 Université De Genève Anti-mycobacterial vaccines
RS61993B1 (sr) 2013-12-03 2021-07-30 Hookipa Biotech Gmbh Cmv vakcine
US10342861B2 (en) * 2014-05-27 2019-07-09 University Of Rochester Arenavirus vaccine
IL261757B2 (en) 2016-03-18 2023-09-01 Univ Rutgers Treatment of stem cells with chemotherapeutic agents conjugated to anti-matriptase antibodies using connecting parts that can be broken down in the living body
KR102446014B1 (ko) * 2022-04-19 2022-09-23 주식회사 웰에이블 저시력자용 진단키트 전용 커버

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADRIAN CIUREA 等: "Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice", 《PNAS》 *
DAVID G. BESSELSEN等: "Detection of Lymphocytic Choriomeningitis Virus by Use of Fluorogenic Nuclease Reverse Transcriptase-Polymerase Chain Reaction Analysis", 《COMPARATIVE MEDICINE》 *
DENISE J. JAMIESON等: "Lymphocytic choriomeningitis virus: An emerging obstetric pathogen?", 《AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY》 *
JANA TOMASKOVA等: "Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX", 《VIRUS GENES》 *
MCCAUSLAND等: "Quantitative PCR (QPCR) technique for detecting lymphocytic choriomeningitis virus (LCMV) in vivo", 《VIROL METHODS》 *
SIMON VIETH等: "RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene", 《TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996802A (zh) * 2018-09-12 2021-06-18 阿巴洛斯治疗有限公司 用于制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体
CN119080935A (zh) * 2024-10-11 2024-12-06 上海市同仁医院 一种抗人SMIM45-107aa单克隆抗体及其用途
CN119080935B (zh) * 2024-10-11 2026-04-14 上海市同仁医院 一种抗人SMIM45-107aa单克隆抗体及其用途

Also Published As

Publication number Publication date
US8883429B2 (en) 2014-11-11
CA2823876A1 (en) 2012-07-12
EP2661509A2 (en) 2013-11-13
JP2014502848A (ja) 2014-02-06
AU2012204757A1 (en) 2013-05-02
WO2012093340A2 (en) 2012-07-12
EP2664680A1 (en) 2013-11-20
US20120237922A1 (en) 2012-09-20
WO2012093340A3 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
CN105378099B (zh) Hcv核心脂质结合结构域单克隆抗体
US8883429B2 (en) Viral diagnostics
KR101785290B1 (ko) 중증 열성 혈소판 감소 증후군 바이러스 감염 진단용 단클론항체, 이를 생산하는 하이브리도마 및 이 단클론항체를 사용하는 중증 열성 혈소판 감소 증후군 바이러스 감염 진단방법
CN110383068A (zh) 评估患者样品中uch-l1状态的改进方法
US12188053B2 (en) Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses
WO2023088444A1 (zh) 一种抗hiv-1 p24的抗体及其制备方法和用途
WO2023088443A1 (zh) 一种抗人IgM抗体及其制备方法和用途
JP2017505124A (ja) ヘンドラ及びニパウイルスのf糖タンパク質に対する抗体
WO2021209824A1 (en) Methods and products for serological analysis of sars-cov-2 infection
US12534512B2 (en) Human monoclonal antibodies to hantavirus and methods of use therefore
CN104024275A (zh) 对于人β1-肾上腺素受体(β1-AR)的结合化合物以及它们在测量自身抗β1-AR抗体中的应用
CN102232087A (zh) 修饰的人igf-1/e肽的抗体
JP2024541945A (ja) SARS-CoV-2受容体結合ドメイン抗体
US20250347699A1 (en) Sars-cov-2 polypeptide, anti-sars-cov-2 antibodies and uses thereof
ES2660372T3 (es) Sustancias y procedimientos para la utilización en la prevención y/o el tratamiento en la enfermedad de Huntington
WO2018140242A1 (en) Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
Fayaz et al. Development and characterization of mouse monoclonal antibodies to canine morbillivirus
CN118772269A (zh) 一种抗副流感病毒3型np蛋白的抗体及其应用
US20230054956A1 (en) Human monoclonal antibodies that neutralize pandemic gii.4 noroviruses
US20240069037A1 (en) Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
US20220043000A1 (en) Methods and kits for detecting sars-cov-2 protein in a sample
US20240124562A1 (en) Monoclonal antibodies and uses thereof
US11174310B2 (en) Disulfide-type HMGB1-specific antibody, method for measuring disulfide-type HMGB1 and kit for said measurement, and measurement method capable of quantitating all of HMGB1 molecules including reduced HMGB1, disulfide-type HMGB1 and thrombin-cleavable HMGB1 and kit for said measurement
CN110412267A (zh) 犬副流感病毒单克隆抗体及其应用
EP1765867B1 (en) Monoclonal antibodies to hiv-1 vpr and methods of using same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140219